Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New antileukemia agents synthesized at Hughes Institute

March 30, 1999

New differentiation-inducing vitamin D compounds from Japanese lab

March 30, 1999

U. of California reports new purine cyclin-dependent kinase inhibitors

March 30, 1999

NCI initiates pilot trial of thalidomide as adjunct in cancer therapy

March 30, 1999

Bioniche technology offers synergistic benefits in cancer therapy

March 29, 1999

Sugen's new protein tyrosine kinase inhibitors

March 26, 1999

Searle characterizes new vitronectin antagonist with antitumor activity at ACS meeting

March 25, 1999

MethylGene initiates phase I clinical trials of MG-98 for solid tumors

March 25, 1999

DuPont presents 4-aminoquinazoline cyclin-dependent kinase inhibitors

March 24, 1999

High-affinity RARalpha receptor agonists reported by Eisai at ACS meeting

March 24, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...